CLDN18.2 binding molecule patent granted to Sanyou
Summary
CLDN18.2 binding molecule patent granted to Sanyou
Archived snapshot
Apr 7, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
CLDN18.2 binding molecule
Grant US12595302B2 Kind: B2 Apr 07, 2026
Assignee
SANYOU BIOPHARMACEUTICALS CO., LTD.
Inventors
Yongcong Tan, Guojun Lang, Chao Kong, Chanjuan Liu, Min Deng, Qi Wu, Jing Zhang, Wenhai Zhang, Baoguo Fan
Abstract
Disclosed is a novel CLDN18.2 binding molecule. Also disclosed are a nucleic acid molecule encoding the CLDN18.2 binding molecule, an expression vector and a host cell for expressing the CLDN18.2 binding molecule. Further disclosed are a method for producing the CLDN18.2 binding molecule and use thereof.
CPC Classifications
C07K 16/28 C07K 2317/24 C07K 2317/565 C07K 2317/569 C07K 16/30 C07K 2317/22 C07K 2317/33 C07K 2317/34 C07K 2317/64 C07K 2317/732 C07K 2317/734 C07K 2317/76 C07K 2317/77 C07K 2317/92 A61P 35/00 A61K 39/00 A61K 2039/505 C12N 15/70 C12N 15/81 C12N 15/85
Filing Date
2020-05-21
Application No.
17613440
Claims
12
Related changes
Get daily alerts for USPTO Patent Grants - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.